WHO retracts opioid guidelines after accepting that industry had an influence
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m105 (Published 10 January 2020) Cite this as: BMJ 2020;368:m105- Owen Dyer
- Montreal
The World Health Organization has formally retracted its two main guidelines on the use of opioids for pain control, after its own review lent credence to outside complaints that the drafting process had been unduly influenced by opioid manufacturers, notably Purdue Pharma’s international subsidiary Mundipharma.
The retraction notice was published in the January issue of the Bulletin of the World Health Organization.1 The retracted guidelines are Ensuring Balance in National Policies on Controlled Substances,2 published in 2011, and WHO Guidelines on the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.